Gemzar (Gemcitabine Hcl) Drug Information: Description, User Reviews, Drug Side Effects, Interactions

Pill Identifier Search

February 9, 2012

Gemzar

Breast Cancer Clinical Trials »

What Is a Clinical Trial?

A clinical trial is a research program conducted with patients to evaluate a new medical treatment, drug or device. The purpose of a breast cancer clinical trial is to find new and improved methods of treating the disease. Clinical trials make it possible to apply the latest scientific and technological advances to patient care.

During a breast cancer clinical trial, researchers, usually physicians, use the best available treatment as a standard to evaluate new treatments. These treatments may be a new drug, surgery or an alternative medicine.

First, researchers study new treatment options in the laboratory in test tubes and animals. If those results are promising, new treatments are further evaluated in a small group of people, and, finally, in a larger clinical trial.

When a new medical treatment is studied for the first time in humans, no one knows exactly how it will work. With any new treatment, there are possible risks as well as be...

Read the Breast Cancer Clinical Trials article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
next »

Gemzar User Reviews >>

Gemzar

Ovarian Cancer Slideshow Pictures

font size

GEMZAR
(gemcitabine for injection) Powder, Lyophilized, For Solution For Intravenous Use

DRUG DESCRIPTION

Gemzar (gemcitabine for injection, USP) is a nucleoside metabolic inhibitor that exhibits antitumor activity. Gemcitabine HC1 is 2'-deoxy-2',2'-difluorocytidine monohydrochloride (β-isomer).

The structural formula is as follows:

GEMZAR
(gemcitabine for injection) Powder Structural Formula Illustration

The empirical formula for gemcitabine HC1 is C₉H₁₁F₂N₃O₄·HCI It has a molecular weight of 299.66.

Gemcitabine HC1 is a white to off-white solid. It is soluble in water, slightly soluble in methanol, and practically insoluble in ethanol and polar organic solvents.

The clinical formulation is supplied in a sterile form for intravenous use only. Vials of Gemzar (gemcitabine hcl) contain either 200 mg or 1 g of gemcitabine HC1 (expressed as free base) formulated with mannitol (200 mg or 1 g, respectively) and sodium acetate (12.5 mg or 62.5 mg, respectively) as a sterile lyophilized powder. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment.

What are the possible side effects of gemcitabine (Gemzar)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

pale skin, easy bruising or bleeding, unusual weakness;
urinating less than usual or not at all;
nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
chest pain or heavy feeling, pain...

Read All Potential Side Effects and See Pictures of Gemzar »

What are the precautions when taking gemcitabine hcl (Gemzar)?

Before using gemcitabine, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: bone marrow problems (e.g., leukopenia, thrombocytopenia, anemia), heart problems (e.g., irregular heartbeat, heart failure), kidney problems, liver problems, radiation therapy.

Do not have immunizations/vaccinations without the consent of your doctor, and avoid contact with people who have recently received oral polio vaccine.

Wash your hands well to prevent the spread of infections.

To lower the chance...

Read All Potential Precautions of Gemzar »

Last reviewed on RxList: 4/4/2011
This monograph has been modified to include the generic and brand name in many instances.